Texas Children Hospital and Baylor College of Medicine announced on Tuesday (local time) that Corbevax, a protein sub-unit COVID-19 vaccine, whose technology
Texas Children Hospital and Baylor College of Medicine announced on Tuesday (local time) that Corbevax, a protein sub-unit COVID-19 vaccine, whose technology
The Central Drug Authority has approved two more Covid vaccines - Corbevax and Covovax - and antiviral drug Molnupiravir for use in India. India's Ambassador to the US described the move as a model of India-US healthcare collaboration.
Washington, December 29
India-US collaboration in the health sector is in the spotlight as the Central Drug Authority this week approved two more Covid vaccines – Corbevax and Covovax – a
Good news amid the fight against Covid! This Friday November 19, 2021, the European Medicines Agency announced they have approved the emergency use of molnupiravir (Lafevrio), and said they will decide on commercialization within a "few weeks".